388 related articles for article (PubMed ID: 24971935)
1. HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches.
Tornesello ML; Perri F; Buonaguro L; Ionna F; Buonaguro FM; Caponigro F
Cancer Lett; 2014 Sep; 351(2):198-205. PubMed ID: 24971935
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis.
Gillison ML; Alemany L; Snijders PJ; Chaturvedi A; Steinberg BM; Schwartz S; Castellsagué X
Vaccine; 2012 Nov; 30 Suppl 5():F34-54. PubMed ID: 23199965
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
Ang KK; Sturgis EM
Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
[TBL] [Abstract][Full Text] [Related]
5. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Brandsma J; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
J Clin Oncol; 2006 Feb; 24(5):736-47. PubMed ID: 16401683
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive meta-analytical summary on human papillomavirus association with head and neck cancer.
Bychkov VA; Nikitina EG; Ibragimova MK; Kaigorodova EV; Choinzonov EL; Litviakov NV
Exp Oncol; 2016 Jun; 38(2):68-72. PubMed ID: 27356572
[TBL] [Abstract][Full Text] [Related]
7. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
[TBL] [Abstract][Full Text] [Related]
8. What are the implications of human papillomavirus status in oropharyngeal tumors for clinical practice?
Klozar J; Tachezy R
Curr Opin Otolaryngol Head Neck Surg; 2014 Apr; 22(2):90-4. PubMed ID: 24492854
[TBL] [Abstract][Full Text] [Related]
9. Oropharyngeal cancer - is it time to change management according to human papilloma virus status?
Mehanna H; Olaleye O; Licitra L
Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):120-4. PubMed ID: 22327790
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and treatment strategy for HPV-related oropharyngeal cancer.
Okami K
Int J Clin Oncol; 2016 Oct; 21(5):827-835. PubMed ID: 27380170
[TBL] [Abstract][Full Text] [Related]
11. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
Fung N; Faraji F; Kang H; Fakhry C
Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
[TBL] [Abstract][Full Text] [Related]
12. What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer?
Urban D; Corry J; Rischin D
Cancer; 2014 May; 120(10):1462-70. PubMed ID: 24578320
[TBL] [Abstract][Full Text] [Related]
13. Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival.
Cai C; Chernock RD; Pittman ME; El-Mofty SK; Thorstad WL; Lewis JS
Am J Surg Pathol; 2014 Jun; 38(6):809-15. PubMed ID: 24698966
[TBL] [Abstract][Full Text] [Related]
14. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
Forte T; Niu J; Lockwood GA; Bryant HE
Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus (HPV) in head and neck cancer.
Syrjänen S
J Clin Virol; 2005 Mar; 32 Suppl 1():S59-66. PubMed ID: 15753013
[TBL] [Abstract][Full Text] [Related]
16. Sexual health in oral oncology: breaking the news to patients with human papillomavirus-positive oropharyngeal cancer.
Evans M; Powell NG
Head Neck; 2014 Nov; 36(11):1529-33. PubMed ID: 24913820
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic strategies for systemic therapies of human papillomavirus-related oropharyngeal cancer.
Hung TKW; Ho AL; Pfister DG
J Surg Oncol; 2021 Nov; 124(6):952-961. PubMed ID: 34585389
[TBL] [Abstract][Full Text] [Related]
18. HPV-induced oropharyngeal cancer, immune response and response to therapy.
Vu HL; Sikora AG; Fu S; Kao J
Cancer Lett; 2010 Feb; 288(2):149-55. PubMed ID: 19628331
[TBL] [Abstract][Full Text] [Related]
19. Management of human papillomavirus-positive and human papillomavirus-negative head and neck cancer.
Mehra R; Ang KK; Burtness B
Semin Radiat Oncol; 2012 Jul; 22(3):194-7. PubMed ID: 22687943
[TBL] [Abstract][Full Text] [Related]
20. HPV-Associated Head and Neck Cancer: Unique Features of Epidemiology and Clinical Management.
Maxwell JH; Grandis JR; Ferris RL
Annu Rev Med; 2016; 67():91-101. PubMed ID: 26332002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]